[MPWG] Fw: 10 scholarships to the BioExec Institute 2007

[Patricia_DeAngelis at fws.gov]

Passing along scholarship information.  Contact information is in the 
e-mail below.


----- Forwarded by Patricia De Angelis/ARL/R9/FWS/DOI on 07/10/2007 03:39 
PM -----

BioExec Institute <bioexec at prescienceintl.com> 
07/10/2007 12:24 PM
Please respond to
bioexec at prescienceintl.com


To
patricia_deangelis at fws.gov
cc

Subject
10 scholarships to the BioExec Institute 2007







View this email on the web: visit 
www.prescienceintl.com/email/BioExec2007_07.10.htm
Dear Patricia, 

UC Berkeley and Deloitte & Touche USA LLP are proud to offer 10 
scholarships to the BioExec Institute 2007. Part of the success of this 
program has been the diversity and depth of its participants, which has 
created a strong and powerful alumni network in this industry. We would 
therefore like to offer scholarships to the leadership of small companies 
with annual revenues under $10M and to academics, governmental and/or 
non-profit organizations. These scholarships finance 50% of the program. 

This is a rolling application process. Please click here for the 
application form and submit to Chelsea Hewitt at 
chelsea at prescienceintl.com. You will be notified if your application is 
accepted within one week of your submission. 

Best, 

Melinda Richter 
Prescience Intl
Partner of UC Berkeley, Haas School of Business, Center for Executive 
Development. 
“The BioExec Institute was exceptional in the quality of the speakers and 
content provided.
I would recommend this program to anyone interested in learning 
strategically about the Biotech industry.” 
- Mike Norris, VP of Corporate Development, CardioVascular 
BioTherapeutics, Inc. 



The Road to Leadership 
The BioExec Institute is an internationally renowned executive program 
delivered by leaders in the industry to director and vice president-level 
management who are searching for the keys to managing business trade-offs 
within a highly regulated and competitive industry. Alongside BioExec 
Institute faculty and alumni, attendees will participate in a six-day 
interactive program, including three evening networking receptions: “A 
View of San Francisco,” “Wine Tasting in the Valley” and “Cultural 
Perspectives.” Participants will have unique opportunities to debate the 
strategies and tactics of business leadership within BioPharma and will 
complete the program with invaluable insight and powerful networks to 
deliver bottom-line value in this growing industry. 

For complete program details and more information visit 
deloitte.com/us/bioexec2007. 

Module A - Creating Value - September 10 & 11 
[Opening Night] Global Industry Context from a San Francisco View Point 
[Day 1] BioProduct Development & Management
[Day 2] Manufacturing & Operations

Faculty and Guest Speakers: click here for bios
Terri A. Cooper, Ph.D., Principal, Deloitte Consulting LLP 
Keith Donnermeyer, U.S. AERS Managing Partner, Life Sciences, Deloitte & 
Touche LLP 
Chris Horan, Vice President, Planning, Distribution and Logistics, 
Genentech Inc.
Matthew K. Hudes, U.S. Managing Principal, Biotechnology, Deloitte 
Consulting LLP 
Denise Hudson, Vice President of Operations, Johnson & Johnson Development 
Corporation 
Abhay Joshi, Ph.D., Executive Vice President and Chief Technical Officer, 
CoTherix, Inc.
Dan Maher, VP Product Development, Biomarin
Gareth Morgan, Executive Director, Central Clinical Operations, 
Bristol-Myers Squibb
Theresa Musser, Executive Director of Development Operations, Rigel 
Pharmaceuticals 
Eric Patzer, President and CEO Aridis Pharmaceuticals, LLC
Michael E. Raynor, Author, The Strategy Paradox & The Innovator's Solution
; Distinguished Fellow with Deloitte Research, Deloitte Consulting LLP 

Module B - Managing Value - October 8 & 9 
[Day 3] IP Challenges & Opportunities
[Wine Tasting] Networking 
[Day 4] Political & Regulatory Strategies

Faculty and Guest Speakers: click here for bios
Simon Gisby, Managing Director, Deloitte & Touche Corporate Finance LLC
R.T. (Terry) Hisey, Vice Chairman and U.S. Managing Principal, Life 
Sciences, Deloitte Consulting LLP
Paul H. Keckley, Ph.D., Executive Director of the Deloitte Center for 
Health Solutions
David A. Kessler, M.D., Dean & Vice Chancellor for Medical Affairs, UCSF 
School of Medicine, and former Commissioner of the US Federal and Drug 
Administration 
Lucy Rose, President, Lucy Rose and Associates, LLC; Former Director of 
the Office of Training and Communications and DDMAC, CDER, FDA
Barbara A. Ryan, Pharma Analyst, Managing Director, Deutsche Bank 
Securities Inc. 

Module C - Growing Value - November 12 & 13 
[Day 5] The Business of Portfolio Management and Market Strategy
[Day 6] The Transformational Journey of Growth by Partnerships
[Final Soiree] Closing Celebration

Faculty and Guest Speakers: click here for bios
Martin Babler, Vice President, Immunology Sales and Marketing, Genentech, 
Inc. 
John T. Bigalke, Vice Chairman and U.S. Managing Partner, Health Sciences 
& Government, Deloitte & Touche LLP
Chris Boerner, PhD Group Product Manager, Xolair Marketing Genentech, Inc. 
(TBC)
Steve Burrill, CEO Burrill & Company 
Keith Donnermeyer, U.S. AERS Managing Partner, Life Sciences, Deloitte & 
Touche LLP 
Harris Kaplan, CEO, Healogix, LLC & Founder, Migliari-Kaplan
Peter McWilliams, Ph.D. Principal Sanderling Ventures 

Key Audience 
The BioExec Institute has brought together over 300 Participants coming 
from companies such as:
Abgenix; Aemtek; Affymetrix; Alza Corp.; Ambrx; Amgen; Amylin 
Pharmaceuticals; Arcturus Inc.; Bathgate Capital Partners; Baxter; BD 
BioScience; Berlex Laboratories; BioAnalytics Marketing; Biomarin 
Pharmaceutical; BIO; BioScience Forum; Blood Systems Research Institute; 
Blue Shield of California; Boston Scientific Corporation; British 
Consulate-General; CardioVascular BioTherapeutics; Chiron Corporation; 
CHORI; Consulate General of Canada; Cooley Godward LLP; Defense Technology 
Analysts; Deloitte & Touche; Development Economic Western Switzerland; EBD 
Group; EGeen International Corporation; Epitomics; Ernst & Young; Eureka 
Therapeutics; Executive Impact Group; Fenwick & West; Fliesler Meyer LLP; 
Fortune Capital Partners; Genentech, Inc.; Geraldine Brush Cancer Research 
Institute; GIRUS Life Sciences; GlobeImmune; Hewlett Packard; Hoag Cancer 
Center; IMS Health; Intel Life Sciences; Invencor; Jazz Pharmaceuticals; 
Johnson & Johnson; Kaiser Permanente; Lawrence Livermore National 
Laboratory; Life Sciences Business Innovation; Light House Capital 
Partners; Locus Pharmaceuticals; M-Squared; Multispan Inc; Nano Nerve; 
nanoPharmatix; National Genetics Institute; Nuvelo; Origen Therapeutics; 
Pain Therapeutics, Inc.; Pharmatech Associates, Inc.; Roche; San Jose 
BioCenter; San Jose State University; Siemens Medical Solutions; Sonus 
Pharmaceuticals; Spectrum Pharmaceuticals; Squire, Sanders, & Dempsey LLP; 
Stanford Licensing Group; Stanford University; Stanford Medical Center; 
State of California; Strategic Decisions Group; The Bill & Melinda Gates 
Foundation; The Carlock Group; The Institute for OneWorld Health; Two Shea 
Consulting; U.S. Department of Commerce; UC Berkeley; UC Davis; UC Davis 
CONNECT; UCSF; Valentis; VaxGen; Wyeth Pharmaceutical; Zila 
Pharmaceuticals 

Information and Registration 
Registration
Participants attending all three modules will receive a Certificate of 
Completion from UC Berkeley Center for Executive Development, Haas School 
of Business.


Module A (9/10 – 9/11)
$1799
Module B (10/8 – 10/9)
$1799
Module C (11/12 – 11/13)
$1799
EARLY ENROLLMENT RATE by 8/15/07
$4500
Full Program
$4950
Corporate Program (three registrants)
$9900 
Corporate Program EARLY ENROLLMENT
$9000 
 
 
Location 
University of California at Berkeley Center for Executive Development at 
the Haas School of Business 2220 Piedmont Avenue, S-460 Berkeley CA 94720 
US 

Contact 
For more information visit deloitte.com/us/bioexec2007 or contact: 

Within the U.S.: Jennie McGihon, Deloitte Services LP, +1 202 220 2783 or 
jemcgihon at deloitte.com or Chelsea Hewitt, Prescience International, +1 408 
960 2316 or chelsea at prescienceintl.com 

International: Aurelie Gaudin, Prescience International, at +33 681 1040 
96 or aurelie at prescienceintl.com 

PRESCIENCE INTERNATIONAL | 855 Folsom Street #926 | San Francisco, CA | 
94107
b +1 415 297.1883 | f +1 415 974.6739 | e bioexec at prescienceintl.com 
If the above information is not of interest to you, please disregard and
we apologize for any inconvenience this may have caused.
To be removed from further emails, please click on the "unsubscribe" 
button below. 


Forward email


This email was sent to patricia_deangelis at fws.gov, by 
bioexec at prescienceintl.com
Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | 
Privacy Policy.
Email Marketing by


Prescience International | 855 Folsom Street #926 | San Francisco | CA | 
94107 


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.plantconservation.org/pipermail/mpwg_lists.plantconservation.org/attachments/20070710/4d6e2a99/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/jpeg
Size: 104345 bytes
Desc: not available
URL: <http://lists.plantconservation.org/pipermail/mpwg_lists.plantconservation.org/attachments/20070710/4d6e2a99/attachment.jpe>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/gif
Size: 218 bytes
Desc: not available
URL: <http://lists.plantconservation.org/pipermail/mpwg_lists.plantconservation.org/attachments/20070710/4d6e2a99/attachment.gif>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: image/gif
Size: 2137 bytes
Desc: not available
URL: <http://lists.plantconservation.org/pipermail/mpwg_lists.plantconservation.org/attachments/20070710/4d6e2a99/attachment-0001.gif>